Literature DB >> 11395169

Age-related changes in cells and tissues due to advanced glycation end products (AGEs).

M Kasper1, R H Funk.   

Abstract

Advanced glycation end products (AGEs) formed by nonenzymatic glycation and oxidation of proteins accumulate during normal aging and at accelerated rate during the course of diabetes. They play a role in the pathogenesis of several other chronic diseases such as Alzheimer's disease, arthritis, atherosclerosis, pulmonary fibrosis and renal failure. AGE-formation changes the chemical and biological properties of proteins inside and outside of the cell. Binding to specific cell surface receptors induces activation of cellular signaling pathways leading to cellular dysfunction and cell death. AGEs are inducible by oxidative stress and induce oxidative stress. Subject of current studies of cell biologists is the intracellular processing of AGEs, which is accompanied by changes of the endolysosomal compartment.

Entities:  

Year:  2001        PMID: 11395169     DOI: 10.1016/s0167-4943(01)00103-0

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  12 in total

1.  Immunohistochemical localization of advanced glycation end products in pinguecula.

Authors:  Yuichi Kaji; Tetsuro Oshika; Shiro Amano; Fumiki Okamoto; Wakako Koito; Seikoh Horiuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

Review 2.  Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.

Authors:  Bryan N Brown; Martin J Haschak; Samuel T Lopresti; Elizabeth C Stahl
Journal:  Semin Immunol       Date:  2017-05-20       Impact factor: 11.130

3.  Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease.

Authors:  M Butscheid; P Hauptvogel; P Fritz; U Klotz; D M Alscher
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

4.  Advanced glycation end products influence oral cancer cell survival via Bcl-xl and Nrf-2 regulation in vitro.

Authors:  Shun-Yao Ko; Hshin-An Ko; Tzong-Ming Shieh; Tzong-Cherng Chi; Hong-I Chen; Yi-Ting Chen; Ya-Hui Yu; Shu-Han Yang; Shu-Shing Chang
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

Review 5.  Bone quality: the determinants of bone strength and fragility.

Authors:  Hélder Fonseca; Daniel Moreira-Gonçalves; Hans-Joachim Appell Coriolano; José Alberto Duarte
Journal:  Sports Med       Date:  2014-01       Impact factor: 11.136

6.  Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses.

Authors:  Rajko Pokupec; Miro Kalauz; Niksa Turk; Zdenka Turk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

7.  Expression of advanced glycation end-products on sun-exposed and non-exposed cutaneous sites during the ageing process in humans.

Authors:  Maria Crisan; Marian Taulescu; Diana Crisan; Rodica Cosgarea; Alina Parvu; Cornel Cãtoi; Tudor Drugan
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

Review 8.  Role of advanced glycation end products in cellular signaling.

Authors:  Christiane Ott; Kathleen Jacobs; Elisa Haucke; Anne Navarrete Santos; Tilman Grune; Andreas Simm
Journal:  Redox Biol       Date:  2014-01-09       Impact factor: 11.799

9.  Unchanged serum levels of advanced glycation endproducts in patients with liver disease.

Authors:  Moritz Butscheid; Christian Schäfer; Stefanie Brenner; Dominik Alscher; Thomas Mürdter; Toshimitsu Niwa; Matthias Frischmann; Monika Pischetsrieder; Ulrich Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-15       Impact factor: 3.195

10.  Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs.

Authors:  Eun Jung Lee; Ji Young Kim; Sang Ho Oh
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.